{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:20:31Z","timestamp":1784694031174,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["SUBZ.A270.23.062"],"award-info":[{"award-number":["SUBZ.A270.23.062"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virol.2026.110876","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:21:47Z","timestamp":1773332507000},"page":"110876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study"],"prefix":"10.1016","volume":"619","author":[{"given":"Jerzy","family":"\u015awierkot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7589-8404","authenticated-orcid":false,"given":"Kinga Maria","family":"Tyczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Siemaszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Madej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Bia\u0142y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Morgiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Wieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Sokolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kujawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Bogunia-Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.110876_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8874339","article-title":"COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 May bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.virol.2026.110876_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2478\/abm-2024-0022","article-title":"'Evaluation of the relationship between ACE2 G8790A and AT2R A1675G gene polymorphisms in COVID-19 patients with and without lung involvement'","volume":"18","author":"Akcilar","year":"2024","journal-title":"Asian Biomed."},{"key":"10.1016\/j.virol.2026.110876_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5455\/aim.2022.30.191-195","article-title":"Effect of toll-like receptor 7 gene polymorphism and ABO blood groups on the severity of COVID-19 patients","volume":"30","author":"Al-Tamimi","year":"2022","journal-title":"Acta Inf. Med."},{"key":"10.1016\/j.virol.2026.110876_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40246-020-00290-4","article-title":"Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity","volume":"14","author":"Anastassopoulou","year":"2020","journal-title":"Hum. Genom."},{"key":"10.1016\/j.virol.2026.110876_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/15353702231181343","article-title":"Influence of polymorphic variations of IFNL, HLA, and IL-6 genes in severe cases of COVID-19","volume":"248","author":"Ara\u00fajo","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.virol.2026.110876_bib6","article-title":"Vaccines induce homeostatic immunity, generating several secondary benefits","volume":"12","author":"Arunachalam","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.110876_bib7","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.2147\/JIR.S474707","article-title":"Interplay of TLR4 and SARS-CoV-2: unveiling the complex mechanisms of inflammation and severity in COVID-19 infections","volume":"17","author":"Asaba","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.virol.2026.110876_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275988","article-title":"Genetic variants determine intrafamilial variability of SARS-CoV-2 clinical outcomes in 19 Italian families","volume":"17","author":"Azzar\u00e0","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110876_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104773","article-title":"Variants in ACE2; potential influences on virus infection and COVID-19 severity","volume":"90","author":"Bakhshandeh","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virol.2026.110876_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/biomedicines11020451","article-title":"Immune response and molecular mechanisms of cardiovascular adverse effects of spike proteins from SARS-CoV-2 and mRNA vaccines","volume":"11","author":"Bellavite","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.virol.2026.110876_bib11","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.110.1.e4","article-title":"No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine","volume":"110","author":"Belloni","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2026.110876_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.825245","article-title":"The emergence of SARS-CoV-2 variants with a lower antibody response: a genomic and clinical perspective","volume":"9","author":"Biswas","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.virol.2026.110876_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"'Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)'","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.virol.2026.110876_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117798","article-title":"Urinary biomarkers in kidney disease","volume":"555","author":"Canki","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.virol.2026.110876_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975918","article-title":"'MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil'","volume":"13","author":"Castelli","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib16","article-title":"'Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism'","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3343\/alm.2021.41.2.129","article-title":"'Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19'","volume":"41","author":"Choudhary","year":"2021","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.virol.2026.110876_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/jpm13020334","article-title":"'Long COVID: clinical Framing, Biomarkers, and Therapeutic Approaches'","volume":"13","author":"Conti","year":"2023","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.virol.2026.110876_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1199561","article-title":"'ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus'","volume":"14","author":"Devaux","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.110876_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113683","article-title":"'Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: ifn-\u03b3-dependent or independent pathway'","volume":"155","author":"Ding","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.virol.2026.110876_bib22","doi-asserted-by":"crossref","DOI":"10.1017\/S095026882100145X","article-title":"Development and validation of a clinical and genetic model for predicting risk of severe COVID-19","volume":"149","author":"Dite","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virol.2026.110876_bib23","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1039\/D2SC06665C","article-title":"Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives","volume":"14","author":"Dong","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.virol.2026.110876_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12985-024-02298-x","article-title":"Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt","volume":"21","author":"Elnagdy","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2026.110876_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.virol.2026.110876_bib26","article-title":"The role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism","volume":"2017","author":"Farrugia","year":"2017","journal-title":"Int J Inflam"},{"key":"10.1016\/j.virol.2026.110876_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7150\/ijms.67815","article-title":"'Potential Genes Associated with COVID-19 and Comorbidity'","volume":"19","author":"Feng","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.virol.2026.110876_bib28","article-title":"'Toll-like receptors and myocardial inflammation'","volume":"2011","author":"Feng","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1016\/j.virol.2026.110876_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/biomedicines11010052","article-title":"Will omics biotechnologies save Us from future pandemics? Lessons from COVID-19 for vaccinomics and adversomics","volume":"11","author":"Ferraresi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.virol.2026.110876_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2023.11.032","article-title":"Variant rs4986790 of <em>toll-like receptor 4<\/em> affects the signaling and induces cell dysfunction in patients with severe COVID-19","volume":"138","author":"Flores-Gonzalez","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110876_bib31","article-title":"Molecular analysis of hot-spot regions of ACE2 and TMPRSS2 in SARS-CoV-2 \"Invulnerable\" individuals","volume":"15","author":"Galanopoulos","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.virol.2026.110876_bib32","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"'Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response'","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110876_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.759587","article-title":"Angiotensin-converting enzyme genotype\u2013specific immune response contributes to the susceptibility of COVID-19: a nested case\u2013control study","volume":"12","author":"Gong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.virol.2026.110876_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110876_bib18","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/vaccines11071257","article-title":"Influence of the single nucleotide polymorphisms rs12252 and rs34481144 in IFITM3 on the antibody response after vaccination against COVID-19","volume":"11","author":"\u010ciu\u010diulkait\u0117","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2026.110876_bib35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41397-020-0164-3","article-title":"'Association of MICA-129Met\/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis'","volume":"20","author":"Iwaszko","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.virol.2026.110876_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jbspin.2015.06.010","article-title":"Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment","volume":"83","author":"Iwaszko","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.virol.2026.110876_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.virol.2026.110876_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/pharmaceutics11090441","article-title":"Toll-like receptors and relevant emerging therapeutics with reference to delivery methods","volume":"11","author":"Javaid","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virol.2026.110876_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.586111","article-title":"'Host Genetics at the Intersection of Autoimmunity and COVID-19: a Potential Key for Heterogeneous COVID-19 Severity'","volume":"11","author":"Karaderi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s12041-021-01344-9","article-title":"Effect of IFN-Y +874 T\/A polymorphism on clinical manifestations of dengue: a meta-analysis","volume":"100","author":"Kaur","year":"2021","journal-title":"J. Genet."},{"key":"10.1016\/j.virol.2026.110876_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2026.110876_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejcdt.2013.12.002","article-title":"Host genome polymorphisms and tuberculosis infection: what we have to say?","volume":"63","author":"Khalilullah","year":"2014","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"key":"10.1016\/j.virol.2026.110876_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4274\/MMJ.galenos.2025.40460","article-title":"TMPRSS2: a key host factor in SARS-CoV-2 infection and potential therapeutic target","volume":"26","author":"Koyou","year":"2025","journal-title":"Medeni Med J"},{"key":"10.1016\/j.virol.2026.110876_bib45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"'Knife's edge: balancing immunogenicity and reactogenicity in mRNA vaccines'","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.virol.2026.110876_bib46","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.3390\/ijms22168660","article-title":"SARS-CoV-2: understanding the transcriptional regulation of ACE2 and TMPRSS2 and the role of single nucleotide polymorphism (SNP) at codon 72 of p53 in the innate immune response against virus infection","volume":"22","author":"Lodhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110876_bib47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/v17050691","article-title":"Receptor binding for the entry mechanisms of SARS-CoV-2: insights from the original strain and emerging variants","volume":"17","author":"Mahdi","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110876_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/vaccines9030211","article-title":"Immunogenetic predictors of severe COVID-19","volume":"9","author":"Malkova","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2026.110876_bib49","article-title":"'Relevance of TMPRSS2, CD163\/CD206, and CD33 in clinical severity stratification of COVID-19'","volume":"13","author":"Mart\u00ednez-Diz","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3325\/cmj.2024.65.220","article-title":"Association of ACE2 and TMPRSS2 genes variants with disease severity and most important biomarkers in COVID-19 patients in Bosnia and Herzegovina","volume":"65","author":"Meseld\u017ei\u0107","year":"2024","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.virol.2026.110876_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/dxh013","article-title":"Molecular genetic analyses of human NKG2C (KLRC2) gene deletion","volume":"16","author":"Miyashita","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib52","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1007\/s11033-023-08493-3","article-title":"Association between angiotensin-converting enzyme-2 gene polymorphism (rs2106809) with severity and outcome of COVID-19 infection","volume":"50","author":"Mohammadi-Berenjestanaki","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.virol.2026.110876_bib53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/icb.2010.78","article-title":"'Activating and inhibitory receptors of natural killer cells'","volume":"89","author":"Pegram","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2026.110876_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/tpj.2015.21","article-title":"The role of toll-like receptor 4 polymorphisms in vaccine immune response","volume":"16","author":"Pellegrino","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.virol.2026.110876_bib55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/pgs.09.25","article-title":"'Application of pharmacogenomics to vaccines'","volume":"10","author":"Poland","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.virol.2026.110876_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179177","article-title":"Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2","volume":"12","author":"Reinke","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110876_bib57","article-title":"Association of genetic polymorphisms with COVID-19 infection and outcomes: an updated meta-analysis based on 62 studies","volume":"10","author":"Ren","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.virol.2026.110876_bib58","series-title":"Modern Applied Statistics with S}","author":"Ripley","year":"2002"},{"key":"10.1016\/j.virol.2026.110876_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205164","article-title":"Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination?","volume":"20","author":"Ryabkova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110876_bib60","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/v16091371","article-title":"Toll-like receptor genes and risk of latent tuberculosis infection in people infected with HIV-1","volume":"16","author":"Salamaikina","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110876_bib61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/09612033221146700","article-title":"'Interferon-gamma (IFN-\u03b3) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: observation from a meta-analysis'","volume":"32","author":"Sarangi","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.virol.2026.110876_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00005-023-00674-z","article-title":"'Activating NKG2C Receptor: functional Characteristics and Current Strategies in Clinical Applications'","volume":"71","author":"Siemaszko","year":"2023","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.virol.2026.110876_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1227897","article-title":"Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells","volume":"14","author":"Siemaszko","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.111147","article-title":"'Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation'","volume":"85","author":"Siemaszko","year":"2024","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1217206","article-title":"Multi-phasic gene profiling using candidate gene approach predict the capacity of specific antibody production and maintenance following COVID-19 vaccination in Japanese population","volume":"14","author":"Takemoto","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.110876_bib66","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10900-022-01112-5","article-title":"A cross-sectional study of untoward reactions following homologous and heterologous COVID-19 booster immunizations in recipients seventeen years of age and older","volume":"47","author":"Tamburro","year":"2022","journal-title":"J. Community Health"},{"key":"10.1016\/j.virol.2026.110876_bib67","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1034\/j.1398-9995.1999.00099.x","article-title":"Biologic functions of the IFN-gamma receptors","volume":"54","author":"Tau","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.virol.2026.110876_bib68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00432-020-03475-5","article-title":"Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma","volume":"147","author":"Viet","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.virol.2026.110876_bib69","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41436-020-01077-7","article-title":"'Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19'","volume":"23","author":"Vietzen","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.virol.2026.110876_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/vaccines13080882","article-title":"Decrypting the immune symphony for RNA vaccines","volume":"13","author":"Weidensee","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.virol.2026.110876_bib71","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"'Adversomics: a new paradigm for vaccine safety and design'","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2026.110876_bib72","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1038\/s41467-024-48339-5","article-title":"Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes","volume":"15","author":"Xie","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:52:03Z","timestamp":1777459923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":72,"alternative-id":["S0042682226000917"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110876","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110876"}}